CHRISTOPHER MOODY: Open Payments
NPI 1760072474 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,018 in 24 payments from 9 companies in 2025. Trend: 2023 $567 · 2024 $4,810 · 2025 $1,018
Food & beverage: $1,018
| Company | Payments | Amount |
|---|---|---|
| NxStage Medical, Inc. | 4 | $473 |
| Calliditas Therapeutics US Inc. | 3 | $183 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $79 |
| Amgen Inc. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Travere Therapeutics, Inc. | 2 | $41 |
| GENZYME CORPORATION | 1 | $40 |
| Fresenius USA Marketing, Inc. | 2 | $35 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
Products named: LIBERTY SELECT CYCLER, NXSTAGE SYSTEM ONE, TARPEYO, JARDIANCE, FARXIGA, TAVNEOS, FABRAZYME, VELPHORO.
Industry payments across NC — which companies pay providers there.
